 | • レポートコード：QYR2104Z0306 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、肛門・大腸がんのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（手術、放射線療法、結腸直腸癌化学療法、標的療法、免疫療法）、用途別市場規模（病院、外来手術センター、がん研究センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・肛門・大腸がんの市場動向 ・企業の競争状況、市場シェア ・肛門・大腸がんの種類別市場規模（手術、放射線療法、結腸直腸癌化学療法、標的療法、免疫療法） ・肛門・大腸がんの用途別市場規模（病院、外来手術センター、がん研究センター） ・肛門・大腸がんの北米市場規模2016-2027（アメリカ、カナダ） ・肛門・大腸がんのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・肛門・大腸がんのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・肛門・大腸がんの中南米市場規模2016-2027（メキシコ、ブラジル） ・肛門・大腸がんの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Diagnostics、Advaxis、Abbott、Amgen、Atara Biotherapeutics、Bayer、Metabiomics、Beckman Coulter、BeiGene、Boehringer Ingelheim、Clinical Genomics、EDP Biotech、Eli Lilly、Epigenomics、Exact Sciences、Genomictree、Immunovaccine、ISA Pharmaceuticals、Merck） ・結論 |
Market Analysis and Insights: Global Anal and Colorectal Cancer Market
The global Anal and Colorectal Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anal and Colorectal Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anal and Colorectal Cancer market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anal and Colorectal Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anal and Colorectal Cancer market.
Global Anal and Colorectal Cancer Scope and Market Size
Anal and Colorectal Cancer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anal and Colorectal Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Surgery
Radiation therapy
Colorectal cancer chemotherapy
Targeted therapy
Immunotherapy
Segment by Application
Hospitals
Ambulatory surgery centers
Cancer research centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Diagnostics
Advaxis
Abbott
Amgen
Atara Biotherapeutics
Bayer
Metabiomics
Beckman Coulter
BeiGene
Amgen
Atara Biotherapeutics
EDP Biotech
Eli Lilly
Epigenomics
Exact Sciences
Genomictree
Immunovaccine
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anal and Colorectal Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgery
1.2.3 Radiation therapy
1.2.4 Colorectal cancer chemotherapy
1.2.5 Targeted therapy
1.2.6 Immunotherapy
1.3 Market by Application
1.3.1 Global Anal and Colorectal Cancer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory surgery centers
1.3.4 Cancer research centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anal and Colorectal Cancer Market Perspective (2016-2027)
2.2 Anal and Colorectal Cancer Growth Trends by Regions
2.2.1 Anal and Colorectal Cancer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anal and Colorectal Cancer Historic Market Share by Regions (2016-2021)
2.2.3 Anal and Colorectal Cancer Forecasted Market Size by Regions (2022-2027)
2.3 Anal and Colorectal Cancer Industry Dynamic
2.3.1 Anal and Colorectal Cancer Market Trends
2.3.2 Anal and Colorectal Cancer Market Drivers
2.3.3 Anal and Colorectal Cancer Market Challenges
2.3.4 Anal and Colorectal Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anal and Colorectal Cancer Players by Revenue
3.1.1 Global Top Anal and Colorectal Cancer Players by Revenue (2016-2021)
3.1.2 Global Anal and Colorectal Cancer Revenue Market Share by Players (2016-2021)
3.2 Global Anal and Colorectal Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anal and Colorectal Cancer Revenue
3.4 Global Anal and Colorectal Cancer Market Concentration Ratio
3.4.1 Global Anal and Colorectal Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anal and Colorectal Cancer Revenue in 2020
3.5 Anal and Colorectal Cancer Key Players Head office and Area Served
3.6 Key Players Anal and Colorectal Cancer Product Solution and Service
3.7 Date of Enter into Anal and Colorectal Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anal and Colorectal Cancer Breakdown Data by Type
4.1 Global Anal and Colorectal Cancer Historic Market Size by Type (2016-2021)
4.2 Global Anal and Colorectal Cancer Forecasted Market Size by Type (2022-2027)
5 Anal and Colorectal Cancer Breakdown Data by Application
5.1 Global Anal and Colorectal Cancer Historic Market Size by Application (2016-2021)
5.2 Global Anal and Colorectal Cancer Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Anal and Colorectal Cancer Market Size (2016-2027)
6.2 North America Anal and Colorectal Cancer Market Size by Type
6.2.1 North America Anal and Colorectal Cancer Market Size by Type (2016-2021)
6.2.2 North America Anal and Colorectal Cancer Market Size by Type (2022-2027)
6.2.3 North America Anal and Colorectal Cancer Market Size by Type (2016-2027)
6.3 North America Anal and Colorectal Cancer Market Size by Application
6.3.1 North America Anal and Colorectal Cancer Market Size by Application (2016-2021)
6.3.2 North America Anal and Colorectal Cancer Market Size by Application (2022-2027)
6.3.3 North America Anal and Colorectal Cancer Market Size by Application (2016-2027)
6.4 North America Anal and Colorectal Cancer Market Size by Country
6.4.1 North America Anal and Colorectal Cancer Market Size by Country (2016-2021)
6.4.2 North America Anal and Colorectal Cancer Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Anal and Colorectal Cancer Market Size (2016-2027)
7.2 Europe Anal and Colorectal Cancer Market Size by Type
7.2.1 Europe Anal and Colorectal Cancer Market Size by Type (2016-2021)
7.2.2 Europe Anal and Colorectal Cancer Market Size by Type (2022-2027)
7.2.3 Europe Anal and Colorectal Cancer Market Size by Type (2016-2027)
7.3 Europe Anal and Colorectal Cancer Market Size by Application
7.3.1 Europe Anal and Colorectal Cancer Market Size by Application (2016-2021)
7.3.2 Europe Anal and Colorectal Cancer Market Size by Application (2022-2027)
7.3.3 Europe Anal and Colorectal Cancer Market Size by Application (2016-2027)
7.4 Europe Anal and Colorectal Cancer Market Size by Country
7.4.1 Europe Anal and Colorectal Cancer Market Size by Country (2016-2021)
7.4.2 Europe Anal and Colorectal Cancer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Anal and Colorectal Cancer Market Size (2016-2027)
8.2 Asia-Pacific Anal and Colorectal Cancer Market Size by Type
8.2.1 Asia-Pacific Anal and Colorectal Cancer Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anal and Colorectal Cancer Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anal and Colorectal Cancer Market Size by Type (2016-2027)
8.3 Asia-Pacific Anal and Colorectal Cancer Market Size by Application
8.3.1 Asia-Pacific Anal and Colorectal Cancer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anal and Colorectal Cancer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anal and Colorectal Cancer Market Size by Application (2016-2027)
8.4 Asia-Pacific Anal and Colorectal Cancer Market Size by Region
8.4.1 Asia-Pacific Anal and Colorectal Cancer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anal and Colorectal Cancer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anal and Colorectal Cancer Market Size (2016-2027)
9.2 Latin America Anal and Colorectal Cancer Market Size by Type
9.2.1 Latin America Anal and Colorectal Cancer Market Size by Type (2016-2021)
9.2.2 Latin America Anal and Colorectal Cancer Market Size by Type (2022-2027)
9.2.3 Latin America Anal and Colorectal Cancer Market Size by Type (2016-2027)
9.3 Latin America Anal and Colorectal Cancer Market Size by Application
9.3.1 Latin America Anal and Colorectal Cancer Market Size by Application (2016-2021)
9.3.2 Latin America Anal and Colorectal Cancer Market Size by Application (2022-2027)
9.3.3 Latin America Anal and Colorectal Cancer Market Size by Application (2016-2027)
9.4 Latin America Anal and Colorectal Cancer Market Size by Country
9.4.1 Latin America Anal and Colorectal Cancer Market Size by Country (2016-2021)
9.4.2 Latin America Anal and Colorectal Cancer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anal and Colorectal Cancer Market Size (2016-2027)
10.2 Middle East & Africa Anal and Colorectal Cancer Market Size by Type
10.2.1 Middle East & Africa Anal and Colorectal Cancer Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anal and Colorectal Cancer Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anal and Colorectal Cancer Market Size by Type (2016-2027)
10.3 Middle East & Africa Anal and Colorectal Cancer Market Size by Application
10.3.1 Middle East & Africa Anal and Colorectal Cancer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anal and Colorectal Cancer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anal and Colorectal Cancer Market Size by Application (2016-2027)
10.4 Middle East & Africa Anal and Colorectal Cancer Market Size by Country
10.4.1 Middle East & Africa Anal and Colorectal Cancer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anal and Colorectal Cancer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Details
11.1.2 Abbott Diagnostics Business Overview
11.1.3 Abbott Diagnostics Anal and Colorectal Cancer Introduction
11.1.4 Abbott Diagnostics Revenue in Anal and Colorectal Cancer Business (2016-2021)
11.1.5 Abbott Diagnostics Recent Development
11.2 Advaxis
11.2.1 Advaxis Company Details
11.2.2 Advaxis Business Overview
11.2.3 Advaxis Anal and Colorectal Cancer Introduction
11.2.4 Advaxis Revenue in Anal and Colorectal Cancer Business (2016-2021)
11.2.5 Advaxis Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Anal and Colorectal Cancer Introduction
11.3.4 Abbott Revenue in Anal and Colorectal Cancer Business (2016-2021)
11.3.5 Abbott Recent Development
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Anal and Colorectal Cancer Introduction
11.4.4 Amgen Revenue in Anal and Colorectal Cancer Business (2016-2021)
11.4.5 Amgen Recent Development
11.5 Atara Biotherapeutics
11.5.1 Atara Biotherapeutics Company Details
11.5.2 Atara Biotherapeutics Business Overview
11.5.3 Atara Biotherapeutics Anal and Colorectal Cancer Introduction
11.5.4 Atara Biotherapeutics Revenue in Anal and Colorectal Cancer Business (2016-2021)
11.5.5 Atara Biotherapeutics Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Anal and Colorectal Cancer Introduction
11.6.4 Bayer Revenue in Anal and Colorectal Cancer Business (2016-2021)
11.6.5 Bayer Recent Development
11.7 Metabiomics
11.7.1 Metabiomics Company Details
11.7.2 Metabiomics Business Overview
11.7.3 Metabiomics Anal and Colorectal Cancer Introduction
11.7.4 Metabiomics Revenue in Anal and Colorectal Cancer Business (2016-2021)
11.7.5 Metabiomics Recent Development
11.8 Beckman Coulter
11.8.1 Beckman Coulter Company Details
11.8.2 Beckman Coulter Business Overview
11.8.3 Beckman Coulter Anal and Colorectal Cancer Introduction
11.8.4 Beckman Coulter Revenue in Anal and Colorectal Cancer Business (2016-2021)
11.8.5 Beckman Coulter Recent Development
11.9 BeiGene
11.9.1 BeiGene Company Details
11.9.2 BeiGene Business Overview
11.9.3 BeiGene Anal and Colorectal Cancer Introduction
11.9.4 BeiGene Revenue in Anal and Colorectal Cancer Business (2016-2021)
11.9.5 BeiGene Recent Development
11.10 Boehringer Ingelheim
11.10.1 Boehringer Ingelheim Company Details
11.10.2 Boehringer Ingelheim Business Overview
11.10.3 Boehringer Ingelheim Anal and Colorectal Cancer Introduction
11.10.4 Boehringer Ingelheim Revenue in Anal and Colorectal Cancer Business (2016-2021)
11.10.5 Boehringer Ingelheim Recent Development
11.11 Clinical Genomics
11.11.1 Clinical Genomics Company Details
11.11.2 Clinical Genomics Business Overview
11.11.3 Clinical Genomics Anal and Colorectal Cancer Introduction
11.11.4 Clinical Genomics Revenue in Anal and Colorectal Cancer Business (2016-2021)
11.11.5 Clinical Genomics Recent Development
11.12 EDP Biotech
11.12.1 EDP Biotech Company Details
11.12.2 EDP Biotech Business Overview
11.12.3 EDP Biotech Anal and Colorectal Cancer Introduction
11.12.4 EDP Biotech Revenue in Anal and Colorectal Cancer Business (2016-2021)
11.12.5 EDP Biotech Recent Development
11.13 Eli Lilly
11.13.1 Eli Lilly Company Details
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Anal and Colorectal Cancer Introduction
11.13.4 Eli Lilly Revenue in Anal and Colorectal Cancer Business (2016-2021)
11.13.5 Eli Lilly Recent Development
11.14 Epigenomics
11.14.1 Epigenomics Company Details
11.14.2 Epigenomics Business Overview
11.14.3 Epigenomics Anal and Colorectal Cancer Introduction
11.14.4 Epigenomics Revenue in Anal and Colorectal Cancer Business (2016-2021)
11.14.5 Epigenomics Recent Development
11.15 Exact Sciences
11.15.1 Exact Sciences Company Details
11.15.2 Exact Sciences Business Overview
11.15.3 Exact Sciences Anal and Colorectal Cancer Introduction
11.15.4 Exact Sciences Revenue in Anal and Colorectal Cancer Business (2016-2021)
11.15.5 Exact Sciences Recent Development
11.16 Genomictree
11.16.1 Genomictree Company Details
11.16.2 Genomictree Business Overview
11.16.3 Genomictree Anal and Colorectal Cancer Introduction
11.16.4 Genomictree Revenue in Anal and Colorectal Cancer Business (2016-2021)
11.16.5 Genomictree Recent Development
11.17 Immunovaccine
11.17.1 Immunovaccine Company Details
11.17.2 Immunovaccine Business Overview
11.17.3 Immunovaccine Anal and Colorectal Cancer Introduction
11.17.4 Immunovaccine Revenue in Anal and Colorectal Cancer Business (2016-2021)
11.17.5 Immunovaccine Recent Development
11.18 ISA Pharmaceuticals
11.18.1 ISA Pharmaceuticals Company Details
11.18.2 ISA Pharmaceuticals Business Overview
11.18.3 ISA Pharmaceuticals Anal and Colorectal Cancer Introduction
11.18.4 ISA Pharmaceuticals Revenue in Anal and Colorectal Cancer Business (2016-2021)
11.18.5 ISA Pharmaceuticals Recent Development
11.18 Merck
.1 Merck Company Details
.2 Merck Business Overview
.3 Merck Anal and Colorectal Cancer Introduction
.4 Merck Revenue in Anal and Colorectal Cancer Business (2016-2021)
.5 Merck Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Anal and Colorectal Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgery
Table 3. Key Players of Radiation therapy
Table 4. Key Players of Colorectal cancer chemotherapy
Table 5. Key Players of Targeted therapy
Table 6. Key Players of Immunotherapy
Table 7. Global Anal and Colorectal Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Anal and Colorectal Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Anal and Colorectal Cancer Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Anal and Colorectal Cancer Market Share by Regions (2016-2021)
Table 11. Global Anal and Colorectal Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Anal and Colorectal Cancer Market Share by Regions (2022-2027)
Table 13. Anal and Colorectal Cancer Market Trends
Table 14. Anal and Colorectal Cancer Market Drivers
Table 15. Anal and Colorectal Cancer Market Challenges
Table 16. Anal and Colorectal Cancer Market Restraints
Table 17. Global Anal and Colorectal Cancer Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Anal and Colorectal Cancer Market Share by Players (2016-2021)
Table 19. Global Top Anal and Colorectal Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anal and Colorectal Cancer as of 2020)
Table 20. Ranking of Global Top Anal and Colorectal Cancer Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Anal and Colorectal Cancer Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Anal and Colorectal Cancer Product Solution and Service
Table 24. Date of Enter into Anal and Colorectal Cancer Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Anal and Colorectal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Anal and Colorectal Cancer Revenue Market Share by Type (2016-2021)
Table 28. Global Anal and Colorectal Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Anal and Colorectal Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Anal and Colorectal Cancer Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Anal and Colorectal Cancer Revenue Market Share by Application (2016-2021)
Table 32. Global Anal and Colorectal Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Anal and Colorectal Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Anal and Colorectal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Anal and Colorectal Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Anal and Colorectal Cancer Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Anal and Colorectal Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Anal and Colorectal Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Anal and Colorectal Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Anal and Colorectal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Anal and Colorectal Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Anal and Colorectal Cancer Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Anal and Colorectal Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Anal and Colorectal Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Anal and Colorectal Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Anal and Colorectal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Anal and Colorectal Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Anal and Colorectal Cancer Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Anal and Colorectal Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Anal and Colorectal Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Anal and Colorectal Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Anal and Colorectal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Anal and Colorectal Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Anal and Colorectal Cancer Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Anal and Colorectal Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Anal and Colorectal Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Anal and Colorectal Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Anal and Colorectal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Anal and Colorectal Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Anal and Colorectal Cancer Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Anal and Colorectal Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Anal and Colorectal Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Anal and Colorectal Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 64. Abbott Diagnostics Company Details
Table 65. Abbott Diagnostics Business Overview
Table 66. Abbott Diagnostics Anal and Colorectal Cancer Product
Table 67. Abbott Diagnostics Revenue in Anal and Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 68. Abbott Diagnostics Recent Development
Table 69. Advaxis Company Details
Table 70. Advaxis Business Overview
Table 71. Advaxis Anal and Colorectal Cancer Product
Table 72. Advaxis Revenue in Anal and Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 73. Advaxis Recent Development
Table 74. Abbott Company Details
Table 75. Abbott Business Overview
Table 76. Abbott Anal and Colorectal Cancer Product
Table 77. Abbott Revenue in Anal and Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 78. Abbott Recent Development
Table 79. Amgen Company Details
Table 80. Amgen Business Overview
Table 81. Amgen Anal and Colorectal Cancer Product
Table 82. Amgen Revenue in Anal and Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 83. Amgen Recent Development
Table 84. Atara Biotherapeutics Company Details
Table 85. Atara Biotherapeutics Business Overview
Table 86. Atara Biotherapeutics Anal and Colorectal Cancer Product
Table 87. Atara Biotherapeutics Revenue in Anal and Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 88. Atara Biotherapeutics Recent Development
Table 89. Bayer Company Details
Table 90. Bayer Business Overview
Table 91. Bayer Anal and Colorectal Cancer Product
Table 92. Bayer Revenue in Anal and Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 93. Bayer Recent Development
Table 94. Metabiomics Company Details
Table 95. Metabiomics Business Overview
Table 96. Metabiomics Anal and Colorectal Cancer Product
Table 97. Metabiomics Revenue in Anal and Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 98. Metabiomics Recent Development
Table 99. Beckman Coulter Company Details
Table 100. Beckman Coulter Business Overview
Table 101. Beckman Coulter Revenue in Anal and Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 102. Beckman Coulter Recent Development
Table 103. BeiGene Company Details
Table 104. BeiGene Business Overview
Table 105. BeiGene Anal and Colorectal Cancer Product
Table 106. BeiGene Revenue in Anal and Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 107. BeiGene Recent Development
Table 108. Boehringer Ingelheim Company Details
Table 109. Boehringer Ingelheim Business Overview
Table 110. Boehringer Ingelheim Anal and Colorectal Cancer Product
Table 111. Boehringer Ingelheim Revenue in Anal and Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 112. Boehringer Ingelheim Recent Development
Table 113. Clinical Genomics Company Details
Table 114. Clinical Genomics Business Overview
Table 115. Clinical Genomics Anal and Colorectal Cancer Product
Table 116. Clinical Genomics Revenue in Anal and Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 117. Clinical Genomics Recent Development
Table 118. EDP Biotech Company Details
Table 119. EDP Biotech Business Overview
Table 120. EDP Biotech Anal and Colorectal Cancer Product
Table 121. EDP Biotech Revenue in Anal and Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 122. EDP Biotech Recent Development
Table 123. Eli Lilly Company Details
Table 124. Eli Lilly Business Overview
Table 125. Eli Lilly Anal and Colorectal Cancer Product
Table 126. Eli Lilly Revenue in Anal and Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 127. Eli Lilly Recent Development
Table 128. Epigenomics Company Details
Table 129. Epigenomics Business Overview
Table 130. Epigenomics Anal and Colorectal Cancer Product
Table 131. Epigenomics Revenue in Anal and Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 132. Epigenomics Recent Development
Table 133. Exact Sciences Company Details
Table 134. Exact Sciences Business Overview
Table 135. Exact Sciences Anal and Colorectal Cancer Product
Table 136. Exact Sciences Revenue in Anal and Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 137. Exact Sciences Recent Development
Table 138. Genomictree Company Details
Table 139. Genomictree Business Overview
Table 140. Genomictree Anal and Colorectal Cancer Product
Table 141. Genomictree Revenue in Anal and Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 142. Genomictree Recent Development
Table 143. Immunovaccine Company Details
Table 144. Immunovaccine Business Overview
Table 145. Immunovaccine Anal and Colorectal Cancer Product
Table 146. Immunovaccine Revenue in Anal and Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 147. Immunovaccine Recent Development
Table 148. ISA Pharmaceuticals Company Details
Table 149. ISA Pharmaceuticals Business Overview
Table 150. ISA Pharmaceuticals Anal and Colorectal Cancer Product
Table 151. ISA Pharmaceuticals Revenue in Anal and Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 152. ISA Pharmaceuticals Recent Development
Table 153. Merck Company Details
Table 154. Merck Business Overview
Table 155. Merck Anal and Colorectal Cancer Product
Table 156. Merck Revenue in Anal and Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 157. Merck Recent Development
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anal and Colorectal Cancer Market Share by Type: 2020 VS 2027
Figure 2. Surgery Features
Figure 3. Radiation therapy Features
Figure 4. Colorectal cancer chemotherapy Features
Figure 5. Targeted therapy Features
Figure 6. Immunotherapy Features
Figure 7. Global Anal and Colorectal Cancer Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory surgery centers Case Studies
Figure 10. Cancer research centers Case Studies
Figure 11. Anal and Colorectal Cancer Report Years Considered
Figure 12. Global Anal and Colorectal Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Anal and Colorectal Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Anal and Colorectal Cancer Market Share by Regions: 2020 VS 2027
Figure 15. Global Anal and Colorectal Cancer Market Share by Regions (2022-2027)
Figure 16. Global Anal and Colorectal Cancer Market Share by Players in 2020
Figure 17. Global Top Anal and Colorectal Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anal and Colorectal Cancer as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Anal and Colorectal Cancer Revenue in 2020
Figure 19. Global Anal and Colorectal Cancer Revenue Market Share by Type (2016-2021)
Figure 20. Global Anal and Colorectal Cancer Revenue Market Share by Type (2022-2027)
Figure 21. North America Anal and Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Anal and Colorectal Cancer Market Share by Type (2016-2027)
Figure 23. North America Anal and Colorectal Cancer Market Share by Application (2016-2027)
Figure 24. North America Anal and Colorectal Cancer Market Share by Country (2016-2027)
Figure 25. United States Anal and Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Anal and Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Anal and Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Anal and Colorectal Cancer Market Share by Type (2016-2027)
Figure 29. Europe Anal and Colorectal Cancer Market Share by Application (2016-2027)
Figure 30. Europe Anal and Colorectal Cancer Market Share by Country (2016-2027)
Figure 31. Germany Anal and Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Anal and Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Anal and Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Anal and Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Anal and Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Anal and Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Anal and Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Anal and Colorectal Cancer Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Anal and Colorectal Cancer Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Anal and Colorectal Cancer Market Share by Region (2016-2027)
Figure 41. China Anal and Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Anal and Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Anal and Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Anal and Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Anal and Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Anal and Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Anal and Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Anal and Colorectal Cancer Market Share by Type (2016-2027)
Figure 49. Latin America Anal and Colorectal Cancer Market Share by Application (2016-2027)
Figure 50. Latin America Anal and Colorectal Cancer Market Share by Country (2016-2027)
Figure 51. Mexico Anal and Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Anal and Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Anal and Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Anal and Colorectal Cancer Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Anal and Colorectal Cancer Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Anal and Colorectal Cancer Market Share by Country (2016-2027)
Figure 57. Turkey Anal and Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Anal and Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Anal and Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Abbott Diagnostics Revenue Growth Rate in Anal and Colorectal Cancer Business (2016-2021)
Figure 61. Advaxis Revenue Growth Rate in Anal and Colorectal Cancer Business (2016-2021)
Figure 62. Abbott Revenue Growth Rate in Anal and Colorectal Cancer Business (2016-2021)
Figure 63. Amgen Revenue Growth Rate in Anal and Colorectal Cancer Business (2016-2021)
Figure 64. Atara Biotherapeutics Revenue Growth Rate in Anal and Colorectal Cancer Business (2016-2021)
Figure 65. Bayer Revenue Growth Rate in Anal and Colorectal Cancer Business (2016-2021)
Figure 66. Metabiomics Revenue Growth Rate in Anal and Colorectal Cancer Business (2016-2021)
Figure 67. Beckman Coulter Revenue Growth Rate in Anal and Colorectal Cancer Business (2016-2021)
Figure 68. BeiGene Revenue Growth Rate in Anal and Colorectal Cancer Business (2016-2021)
Figure 69. Boehringer Ingelheim Revenue Growth Rate in Anal and Colorectal Cancer Business (2016-2021)
Figure 70. Clinical Genomics Revenue Growth Rate in Anal and Colorectal Cancer Business (2016-2021)
Figure 71. EDP Biotech Revenue Growth Rate in Anal and Colorectal Cancer Business (2016-2021)
Figure 72. Eli Lilly Revenue Growth Rate in Anal and Colorectal Cancer Business (2016-2021)
Figure 73. Epigenomics Revenue Growth Rate in Anal and Colorectal Cancer Business (2016-2021)
Figure 74. Exact Sciences Revenue Growth Rate in Anal and Colorectal Cancer Business (2016-2021)
Figure 75. Genomictree Revenue Growth Rate in Anal and Colorectal Cancer Business (2016-2021)
Figure 76. Immunovaccine Revenue Growth Rate in Anal and Colorectal Cancer Business (2016-2021)
Figure 77. ISA Pharmaceuticals Revenue Growth Rate in Anal and Colorectal Cancer Business (2016-2021)
Figure 78. Merck Revenue Growth Rate in Anal and Colorectal Cancer Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
世界の肛門・大腸がん市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anal and Colorectal Cancer Market The global Anal and Colorectal Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, …- 世界の転移性結腸直腸癌手術市場規模・現状・予測（2021年-2027年） Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…
- 世界の結腸直腸がん市場規模・現状・予測（2021年-2027年） Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). The major symptoms associated with colorectal cancer include diarrhea, constipation, blood in feces, pain in abdomen, loss of appetite, loss of …
- 世界の結腸直腸がん分子診断市場規模・現状・予測（2021年-2027年） Colorectal cancer molecular diagnostics can speed up the identification of colorectal cancer to provide patients with more treatment options. Individualized and targeted treatments are reshaping the colorectal molecular diagnostics market. Molecular pathology is a key factor to personalized medicine…
- 世界の肛門がん治療薬市場規模・現状・予測（2021年-2027年） A cancer can be defined when the normal cells lose their ability to control, their growth or multiplication and thus invade the tissues and spread to the body parts. Anal cancer is often called as squamous cell carcinoma which arises from the cells around or in the anal opening or in rare cases it m…